Although this genetic mutation may have helped us to survive in extreme climates through the ages, research published this week in the journal Nature Genetics suggests that this mutated bone-shortening gene could also be increasing the likelihood of us developing osteoarthritis today.
Arthritis is the single greatest cause of disability in New Zealand, affecting one in six of us over the age of 15. Osteoarthritis starts with the cartilage in our joints becoming thin and uneven over time. As a degenerative disease that particularly affects the hands, feet, spine, hips and knees, osteoarthritis results in the tissues around our joints becoming painful and inflamed, eventually resulting in reduced joint motion and reduced mobility for the sufferer.
Previously, osteoarthritis was thought to be caused by wear-and-tear; however, this new research used a multidisciplinary team that combined the powerful approaches of developmental biology, evolutionary genomics and bioinformatics to show how osteoarthritis is connected to genetic factors as well as lifestyle.
Using data from the 1000 Genomes Project, which catalogued human genotype variation in 2504 individuals from 26 populations, this new study found that those of us carrying the GDF5 gene mutation are almost twice as likely to suffer from osteoarthritis during our lifetime. Aligning with the historical hypothesis, the mutation was also found to be prevalent in Europeans and Asians but rare among African populations.
Because osteoarthritis usually starts after the age of 40, it is likely that with their shorter life expectancies, our early ancestors didn't suffer from the disease before reproductive age and so the benefits of being shorter in colder conditions likely outweighed the risk of developing osteoarthritis later in life.
Currently there is no cure for osteoarthritis and sufferers are offered options to help treat their pain, or to replace whole joints with artificial implants. However, this new study combined with many more looking at variations in the human genome across thousands of individuals has the potential to open up new areas of treatment based on the molecular causes of arthritis.
While many of us are likely to experience the pain and discomfort that comes with osteoarthritis, perhaps in a small way we should be grateful that in doing so we are carrying the legacy of an ancient survival trait which may be the reason why we are here today.
Dr Michelle Dickinson, also known as Nanogirl, is an Auckland University nanotechnologist who is passionate about getting Kiwis hooked on science.
Tweet her your science questions @medickinson.